Positioning of EDI Catheter In Premature Infants

NCT ID: NCT05107713

Last Updated: 2023-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

65 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-01

Study Completion Date

2023-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Nasogastric (NG) and orogastric (OG) feeding tubes have a high incidence of malpositioning, occurring in up to 59% of preterm infants (Lopes 2019). Ideally, the tip of the feeding tube (including the orifices) should be located within the body of the stomach.

Malpositioning of the feeding tube can be classified as (i) being "too far out" where the tip of the catheter is located in the esophagus above the gastro-esophageal junction, potentially resulting in reflux, aspiration, apnea or (ii) being inserted "too far in" where the tip is located in the pylorus or the duodenum, leading to malabsorption of nutrients, diarrhea, and poor weight gain. Feeding tubes can also be found "curled up" inside the stomach (Quandt 2009) as much as 35% of the time. As well, one cannot ignore the risk of perforation, where the incidence has been reported to be 1.1% in extremely low birth weight (ELBW) infants (\<1000g) (n = 7/646) (Thanhaeuser M, 2019); of note: perforations occurred on the third day of life (range days 2-14) not during initial feeding tube placement.

In 2008, a modified feeding tube was introduced to the market (Maquet Critical Care AB), which contains sensors placed in its wall, 13 mm above the feeding orifices, used for measuring the electrical activity of the diaphragm (Edi) during spontaneous breathing. The Edi signal is then used to neurally control mechanical ventilation, or for neural monitoring of the breathing pattern (Sinderby 1999; Beck 2016). The so-called "Edi catheter" comes with the manufacturer's recommended insertion measurements and verification window. In the Servo-I, the insertion distance is provided by a formula on the catheter packaging. In the Servo-U and Servo-n, the calculation for predicted insertion is provided by a tool in the ventilator. There is no available, published data upon which the manufacturer's recommendations were based. It is possible that obtaining appropriate positioning of the Edi catheter - based on a pattern of electrical signals from the sensors - could reduce the incidence of malposition.

This proposed study is observational, and non-interventional. The purpose is to verify the position of a neurally guided, clinically-placed, Edi catheter using radiography (Ellett 2011). We will also record physical measurements and weights of the babies in order to validate previously described methods of predicting insertion length. The x-rays will be taken with "near-simultaneous" screenshots of the Edi catheter positioning window.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nasogastric (NG) and orogastric (OG) feeding tubes have a high incidence of malpositioning, occurring in up to 59% of preterm infants (Lopes 2019). Ideally, the tip of the feeding tube (including the orifices) should be located within the body of the stomach.

Malpositioning of the feeding tube can be classified as (i) being "too far out" where the tip of the catheter is located in the esophagus above the gastro-esophageal junction, potentially resulting in reflux, aspiration, apnea or (ii) being inserted "too far in" where the tip is located in the pylorus or the duodenum, leading to malabsorption of nutrients, diarrhea, and poor weight gain. Feeding tubes can also be found "curled up" inside the stomach (Quandt 2009) as much as 35% of the time. As well, one cannot ignore the risk of perforation, where the incidence has been reported to be 1.1% in extremely low birth weight (ELBW) infants (\<1000g) (n = 7/646) (Thanhaeuser M, 2019); of note: perforations occurred on the third day of life (range days 2-14) not during initial feeding tube placement.

In 2008, a modified feeding tube was introduced to the market (Maquet Critical Care AB), which contains sensors placed in its wall, 13 mm above the feeding orifices, used for measuring the electrical activity of the diaphragm (Edi) during spontaneous breathing. The Edi signal is then used to neurally control mechanical ventilation, or for neural monitoring of the breathing pattern (Sinderby 1999; Beck 2016). The so-called "Edi catheter" comes with the manufacturer's recommended insertion measurements and verification window. In the Servo-I, the insertion distance is provided by a formula on the catheter packaging. In the Servo-U and Servo-n, the calculation for predicted insertion is provided by a tool in the ventilator. There is no available, published data upon which the manufacturer's recommendations were based. It is possible that obtaining appropriate positioning of the Edi catheter - based on a pattern of electrical signals from the sensors - could reduce the incidence of malposition.

This proposed study is observational, and non-interventional. The purpose is to verify the position of a neurally guided, clinically-placed, Edi catheter using radiography (Ellett 2011). The investigators will also record physical measurements and weights of the babies in order to validate previously described methods of predicting insertion length. The x-rays will be taken with "near-simultaneous" screenshots of the Edi catheter positioning window.

The investigators plan on studying a convenience sample of 65 premature babies of varying weights, from 9 sites.

Objective of the study:

To determine if optimal positioning of the Edi catheter results in feeding holes in the stomach in neonates. The aim is to capture a screenshot of the Edi catheter positioning along with one radiograph.

Study design:

This is a multi-centre, observational study.

Procedures:

1. Once the subject is enrolled, if not already inserted, the Edi catheter will be placed as guided by routine clinical practice and fixed in place.
2. Data collection form will be completed.
3. When the placement of the Edi catheter is deemed satisfactory (or may have already been in place), a screenshot or photograph of the catheter positioning window is taken. Clinicians should make an effort to capture a screenshot just prior to or immediately after the radiograph is done, taking effort to maintain the same patient positioning to prevent inadvertent migration of the Edi catheter.
4. Radiograph taken.
5. Send all info to J Beck: package would include de-identified data: Data collection form, screen shot, radiograph.
6. De-identified data will be initially sent to a secure server at Neurovent Research Inc, for then transfer to St-Michael's Hospital (lead site).

Analysis:

Radiographs will be analyzed after-the-fact, by Dr. Kay North, without having information on the catheter positioning window. The location of the tip of the catheter will be classified into one of four categories: 1. Tube tip in esophagus. 2 Tube tip in the region of the GEJ. 3. Tube tip in the stomach. 4. Tube tip in the pylorus. Any other comments would be noted (e.g. curled up catheter, catheter tip impinging on the lateral gastric wall), (Quandt 2009).

Screenshot of positioning window. Two independent analysts from St-Michael's Hospital will determine diaphragm position on the array. With the 6 mm IED catheter we have a resolution of 12 mm.

The measurements on the data collection form about NEX, NEMU and ARHB will be correlated to catheter insertion distance.

Other data will be used for anthropometric information

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Evaluation of Preterm NAVA Catheter Placement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* about to be equipped OR already equipped with a 6F or 8F (49 or 50 cm) Edi feeding tube for clinical or research purposes.
* Babies who are prescribed clinically or for research purposes, to have a chest/abdominal radiograph. Babies may be breathing on NAVA, NIV-NAVA or neural monitoring during a conventional mode or HFO, or nCPAP/HFNC.
* Placement of a second feeding tube is permitted, as well as oral or nasal feeding tube insertion.

Our goal is to study a minimum of 65 babies. We will try to obtain data from the following (6) weight categories with a minimum of 10 babies in each category, except the smallest group where we anticipate positioning to be more challenging, based on anatomical modelling:

400-750g (n= 15 babies) 750-1000g (n = 10 babies) 1000-1250g (n = 10 babies) 1250-1500g (n = 10 babies) 1500-1750g (n = 10 babies) 1750-2000g (n = 10 babies). The investigators are aware that not all centres use Edi catheters in all the different weight groups.

\-

Exclusion Criteria

Previous gastric surgery, anatomical abnormalities. Further reasons for exclusion will be left to the clinicians at each site.

\-
Minimum Eligible Age

1 Day

Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unity Health Toronto

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Unity Health

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-078

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.